Investing.com - Minerva Neurosciences ने बुधवार को तीसरी तिमाही के नतीजों में विश्लेषकों के अनुमानों को पिछाडा और आय ने के बराबर था करा. कंपनी ने आय प्रति स्टॉक $-1.290 बताया...
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson’s disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
| औसत | 6.0000 (+138.0952% ऊपर) |
| उच्च | 8.0000 |
| निम्न | 3.0000 |
| क़ीमत | 2.5200 |
| विश्लेषकों की संख्या | 3 |
प्रकार | 5 मिनट | 15 मिनट | प्रति घंटा | दैनिक | मासिक |
|---|---|---|---|---|---|
| मूविंग एवरेज | |||||
| तकनीकी संकेतक | |||||
| सारांश |
नाम | अंतिम | उच्च | निम्न | बदलाव | बदलाव % | वॉल्यूम | समय | ||
|---|---|---|---|---|---|---|---|---|---|
| 69.05 | 70.55 | 67.75 | -0.95 | -1.36% | 2.35M | NSE | |||
| 165.55 | 166.45 | 162.55 | -1.35 | -0.81% | 11.73M | NSE | |||
| 4.90 | 5.20 | 4.90 | 0.00 | 0.00% | 0.00 | NSE | |||
| 1,856.10 | 1,865.00 | 1,845.10 | +8.15 | +0.44% | 258.82K | NSE | |||
| 0.35 | 0.35 | 0.30 | 0.00 | 0.00% | 0.00 | NSE | |||
| 2,329.00 | 2,349.00 | 2,293.00 | +2.05 | +0.09% | 11.40M | NSE | |||
| 7.95 | 7.95 | 7.95 | 0.00 | 0.00% | 0.00 | BSE | |||
| 21.00 | 21.00 | 19.70 | +0.30 | +1.45% | 1.06K | BSE | |||
| 300.90 | 305.10 | 298.25 | -1.40 | -0.46% | 6.66K | NSE | |||
| 139.00 | 141.50 | 133.25 | 0.00 | 0.00% | 0.00 | NSE | |||
| 643.50 | 655.00 | 635.10 | 0.00 | 0.00% | 0.00 | NSE | |||
| 0.78 | 0.83 | 0.76 | 0.00 | 0.00% | 0.00 | BSE | |||
| 2,210.45 | 2,229.50 | 2,185.00 | +7.65 | +0.35% | 351.81K | NSE | |||
| 25.25 | 25.75 | 24.60 | +0.10 | +0.40% | 3.73K | NSE | |||
| 220.50 | 223.85 | 216.60 | -1.55 | -0.70% | 3.62M | NSE |